TABLE 2.
GSI | ASI-A | ASI-D | PTSD | |
---|---|---|---|---|
n = 930 OR (SE) | n = 332 OR (SE) | n = 433 OR (SE) | n = 615 OR (SE) | |
Cluster 1: Low service use (referent) | — — |
— — |
— — |
— — |
Cluster 2: High-intensity counseling use | 0.837 (0.184) | 1.790 (0.816) | 0.709 (0.320) | 0.943 (0.278) |
Cluster 3: High-level residential treatment use | 0.862 (0.216) | 1.121 (0.557) | 2.319 (1.157) | 1.400 (0.464) |
Cluster 4: Moderate-level residential treatment use | 0.674 (0.158) | 0.679 (0.292) | 1.452 (0.610) | 0.704 (0.128) |
Cluster 5: High psychotropic drug and external medical costs | 0.609* (0.121) | 0.479* (0.179) | 0.597 (0.233) | 0.533** (0.128) |
Wald test of joint significanceb | 2.940 p = .401 |
3.30 p = .347 |
9.03 p = .061 |
3.400 p = .333 |
All models controlled for site-level fixed effects and person-level characteristics, including demographics, illness/disability, insurance, current victimization, perceived need for treatment, mandated treatment, and baseline symptom severity.
GSI, ASI-A, and PTSD model tested for joint significance of coefficients for clusters 2, 3, and 4; ASI-D model tested for joint significance of all model coefficients.
Significant at 5%.
Significant at 1%.